- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Volume 2013 (2013), Article ID 329063, 9 pages
PKCε Phosphorylates and Mediates the Cell Membrane Localization of RhoA
1Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA
2Department of Otolaryngology-Head and Neck Surgery, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA
3Center for Live-Cell Imaging, Department of Microbiology and Immunology, University of Michigan, Ann Arbor, MI 48109, USA
4Division of Hematology and Oncology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48108, USA
5Van Andel Research Institute, Grand Rapids, MI 49503, USA
6Southwest Michigan Innovation Center, Kalamazoo, MI 49008, USA
Received 9 July 2013; Accepted 18 August 2013
Academic Editors: Y.-y. Liu and Y. Yu
Copyright © 2013 Tizhi Su et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- H. Mischak, J. Goodnight, W. Kolch et al., “Overexpression of protein kinase C-δ and -ε in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity,” Journal of Biological Chemistry, vol. 268, no. 9, pp. 6090–6096, 1993.
- G. P. Perletti, M. Folini, H.-C. Lin, H. Mischak, F. Piccinini, and A. H. Tashjian Jr., “Overexpression of protein kinase C epsilon is oncogenic in rat colonic epithelial cells,” Oncogene, vol. 12, no. 4, pp. 847–854, 1996.
- S. D. Tachado, M. W. Mayhew, G. G. Wescott et al., “Regulation of tumor invasion and metastasis in protein kinase C epsilon-transformed NIH3T3 fibroblasts,” Journal of Cellular Biochemistry, vol. 85, no. 4, pp. 785–797, 2002.
- A. P. Jansen, E. G. Verwiebe, N. E. Dreckschmidt, D. L. Wheeler, T. D. Oberley, and A. K. Verma, “Protein kinase C-ε transgenic mice: a unique model for metastatic squamous cell carcinoma,” Cancer Research, vol. 61, no. 3, pp. 808–812, 2001.
- D. Wu, T. L. Foreman, C. W. Gregory et al., “Protein kinase Cε has the potential to advance the recurrence of human prostate cancer,” Cancer Research, vol. 62, no. 8, pp. 2423–2429, 2002.
- F. Benavides, J. Blando, C. J. Perez et al., “Transgenic overexpression of PKCε in the mouse prostate induces preneoplastic lesions,” Cell Cycle, vol. 10, no. 2, pp. 268–277, 2011.
- Q. Pan, L. W. Bao, C. G. Kleer et al., “Protein kinase Cε is a predictive biomarker of aggressive breast cancer and a validated target for RNA interference anticancer therapy,” Cancer Research, vol. 65, no. 18, pp. 8366–8371, 2005.
- Q. Pan, L. W. Bao, T. N. Teknos, and S. D. Merajver, “Targeted disruption of protein kinase Cε reduces cell invasion and motility through inactivation of RhoA and RhoC GTPases in head and neck squamous cell carcinoma,” Cancer Research, vol. 66, no. 19, pp. 9379–9384, 2006.
- X. Zhao, L. Lu, N. Pokhriyal et al., “Overexpression of RhoA induces preneoplastic transformation of primary mammary epithelial cells,” Cancer Research, vol. 69, no. 2, pp. 483–491, 2009.
- L. Ma, Y.-P. Liu, C.-Z. Geng, X.-L. Wang, Y.-J. Wang, and X.-H. Zhang, “Over expression of rhoa is associated with progression in invasive breast duct carcinoma,” Breast Journal, vol. 16, no. 1, pp. 105–107, 2010.
- S. Valastyan, F. Reinhardt, N. Benaich et al., “A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis,” Cell, vol. 137, no. 6, pp. 1032–1046, 2009.
- D.-D. Dittert, C. Kielisch, I. Alldinger et al., “Prognostic significance of immunohistochemical RhoA expression on survival in pancreatic ductal adenocarcinoma: a high-throughput analysis,” Human Pathology, vol. 39, no. 7, pp. 1002–1010, 2008.
- D. Wang, K. Dou, H. Xiang et al., “Involvement of RhoA in progression of human hepatocellular carcinoma,” Journal of Gastroenterology and Hepatology, vol. 22, no. 11, pp. 1916–1920, 2007.
- X. R. Li, F. Ji, J. Ouyang, W. Wu, L. Y. Qian, and K. Y. Yang, “Overexpression of RhoA is associated with poor prognosis in hepatocellular carcinoma,” European Journal of Surgical Oncology, vol. 32, no. 10, pp. 1130–1134, 2006.
- A. Horiuchi, T. Imai, C. Wang et al., “Up-regulation of small GTPases, RhoA and RhoC, is associated with tumor progression in ovarian carcinoma,” Laboratory Investigation, vol. 83, no. 6, pp. 861–870, 2003.
- T. Kamai, T. Tsujii, K. Arai et al., “Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer,” Clinical Cancer Research, vol. 9, no. 7, pp. 2632–2641, 2003.
- A. Faried, M. Nakajima, M. Sohda, T. Miyazaki, H. Kato, and H. Kuwano, “Correlation between RhoA overexpression and tumour progression in esophageal squamous cell carcinoma,” European Journal of Surgical Oncology, vol. 31, no. 4, pp. 410–414, 2005.
- M. T. Abraham, M. A. Kuriakose, P. G. Sacks et al., “Motility-related proteins as markers for head and neck squamous cell cancer,” Laryngoscope, vol. 111, no. 7, pp. 1285–1289, 2001.
- R. Niggeweg, T. Köcher, M. Gentzel et al., “A general precursor ion-like scanning mode on quadrupole-TOF instruments compatible with chromatographic separation,” Proteomics, vol. 6, no. 1, pp. 41–53, 2006.
- H. Steen, B. Kuster, M. Fernandez, A. Pandey, and M. Mann, “Detection of tyrosine phosphorylated peptides by precursor ion scanning quadrupole TOF mass spectrometry in positive ion mode,” Analytical Chemistry, vol. 73, no. 7, pp. 1440–1448, 2001.
- A. Hoppe, K. Christensen, and J. A. Swanson, “Fluorescence resonance energy transfer-based stoichiometry in living cells,” Biophysical Journal, vol. 83, no. 6, pp. 3652–3664, 2002.
- A. D. Hoppe and J. A. Swanson, “Cdc42, Rac1, and Rac2 display distinct patterns of activation during phagocytosis,” Molecular Biology of the Cell, vol. 15, no. 8, pp. 3509–3519, 2004.
- J. A. Ubersax and J. E. Ferrell Jr., “Mechanisms of specificity in protein phosphorylation,” Nature Reviews Molecular Cell Biology, vol. 8, no. 7, pp. 530–541, 2007.
- R. M. Biondi and A. R. Nebreda, “Signalling specificity of Ser/Thr protein kinases through docking-site-mediated interactions,” Biochemical Journal, vol. 372, part 1, pp. 1–13, 2003.
- R. Ben-Levy, S. Hooper, R. Wilson, H. F. Paterson, and C. J. Marshall, “Nuclear export of the stress-activated protein kinase p38 mediated by its substrate MAPKAP kinase-2,” Current Biology, vol. 8, no. 19, pp. 1049–1057, 1998.
- P. Lang, F. Gesbert, M. Delespine-Carmagnat, R. Stancou, M. Pouchelet, and J. Bertoglio, “Protein kinase A phosphorylation of RhoA mediates the morphological and functional effects of cyclic AMP in cytotoxic lymphocytes,” EMBO Journal, vol. 15, no. 3, pp. 510–519, 1996.
- V. Sauzeau, M. Rolli-Derkinderen, C. Marionneau, G. Loirand, and P. Pacaud, “RhoA expression is controlled by nitric oxide through cGMP-dependent protein kinase activation,” Journal of Biological Chemistry, vol. 278, no. 11, pp. 9472–9480, 2003.
- M. Rolli-Derkinderen, V. Sauzeau, L. Boyer et al., “Phosphorylation of serine 188 protects RhoA from ubiquitin/proteasome- mediated degradation in vascular smooth muscle cells,” Circulation Research, vol. 96, no. 11, pp. 1152–1160, 2005.
- T. Kallunki, B. Su, I. Tsigelny et al., “JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation,” Genes and Development, vol. 8, no. 24, pp. 2996–3007, 1994.
- S. Lee, X. Lin, N. H. Nam, K. Parang, and G. Sun, “Determination of the substrate-docking site of protein tyrosine kinase C-terminal Src kinase,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 25, pp. 14707–14712, 2003.